1,376 results on '"Piette, Jean"'
Search Results
102. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature
103. Vascular cell adhesion molecule-1 (VCAM-1) plays a central role in the pathogenesis of severe forms of vasculitis due to hepatitis C-associated mixed cryoglobulinemia
104. Small-Vessel Vasculitis Surrounding an Uninflamed Temporal Artery: A New Diagnostic Criterion for Polymyalgia Rheumatica?
105. Modelling of cooking-cooling processes for meat and poultry products
106. Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients
107. La communication dans le club et par le club
108. Whole blood versus serum hydroxychloroquine levels for drug monitoring of patients with systemic lupus erythematosus : prehole blood versus serum hydroxychloroquine levels for drug monitoring of patients with systemic lupus erythematosus : preliminary results of a pharmacological study
109. Decrease in internal jugular endothelin levels after carotid cross-clamping during human carotid revascularization procedures
110. Relationship between blood hydroxychloroquine and desethylchloroquine concentrations and cigarette smoking in treated patients with connective tissue diseases
111. Antiviral therapy for cryoglobulinemic neuropathy: comment on the article by Saadoun et al
112. EASI—The European Autoimmunity Standardisation Initiative: A New Initiative that Can Contribute to Agreed Diagnostic Models of Diagnosing Autoimmune Disorders throughout Europe
113. Bilateral Adrenal Infiltration in Erdheim-Chester Disease. Report of Seven Cases and Literature Review
114. Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus
115. Catastrophic Antiphospholipid Syndrome: Lessons from the “CAPS Registry”—A Tribute to the Late Josep Font
116. Role of matrix metalloproteinases, proinflammatory cytokines, and oxidative stress–derived molecules in hepatitis C virus–associated mixed cryoglobulinemia vasculitis neuropathy
117. Cardiomyopathy Related to Antimalarial Therapy with Illustrative Case Report
118. Treatment of the antiphospholipid syndrome
119. Milestones in the Antiphospholipid Syndrome
120. Dermatologic Manifestations in the Antiphospholipid Syndrome
121. Pediatric and Familial Antiphospholipid Syndromes
122. Renal, Hepatic and other Intraabdominal Manifestations in the Antiphospholipid Syndrome
123. ‘Primary’, ‘Secondary’, ‘Seronegative’, ‘Catastrophic’ and other Subsets of the Antiphospholipid Syndrome
124. Antiviral Therapy for Hepatitis C Virus–Associated Mixed Cryoglobulinemia Vasculitis: A Long-Term Followup Study
125. Increased Risks of Lymphoma and Death Among Patients With Non–Hepatitis C Virus–Related Mixed Cryoglobulinemia
126. Variability in the efficacy of interferon-α in Erdheim-Chester disease by patient and site of involvement: Results in eight patients
127. Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus
128. Aseptic abscesses: a study of 30 patients with or without inflammatory bowel disease and review of the literature
129. Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus
130. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis
131. Long-term outcome in Susac Syndrome
132. Pulmonary Arterial Hypertension Is A Major Mortality Factor in Diffuse Systemic Sclerosis, Independent Of Interstitial Lung Disease
133. Vascular Manifestations in Relapsing Polychondritis
134. Vascular Manifestations in Rheumatoid Arthritis, Dermato/Polymyositis, and Mixed Connective Tissue Disease
135. CASE REPORT: Retropharyngeal and Splenic Aseptic Abscesses Treated with Prednisone and Cyclophosphamide in a Patient with Ulcerative Colitis
136. Induction of Endothelial Cell Apoptosis by the Binding of Anti–Endothelial Cell Antibodies to Hsp60 in Vasculitis-Associated Systemic Autoimmune Diseases
137. Spontaneous Pneumothorax in Wegener Granulomatosis*
138. Involvement of Chemokines and Type 1 Cytokines in the Pathogenesis of Hepatitis C Virus–Associated Mixed Cryoglobulinemia Vasculitis Neuropathy
139. R92Q TNFRSF1A mutation and Behçetʼs disease: Comment on the article by Amoura et al
140. Dermatologic Manifestations of the Antiphospholipid Syndrome: Two Hundred Consecutive Cases
141. Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome
142. PEGylated Interferon Alfa-2b and Ribavirin Treatment in Patients With Hepatitis C Virus–Related Systemic Vasculitis
143. Corrected QT interval in anti-SSA–positive adults with connective tissue disease: comment on the article by Lazzerini et al
144. Association of the R92Q TNFRSF1A Mutation and Extracranial Deep Vein Thrombosis in Patients With Behçetʼs Disease
145. CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis
146. Myositis and Neoplasia
147. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN
148. Les anticorps antiphospholipides, signification et traitement
149. Predominance of type 1 (Th1) cytokine production in the liver of patients with HCV-associated mixed cryoglobulinemia vasculitis
150. Clonal B Cell Populations in the Blood and Liver of Patients With Chronic Hepatitis C Virus Infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.